The claims and ensuing settlement revolve around Biohaven’s CGRP receptor antagonist Nurtec ODT, which is cleared to both treat and prevent migraines in adults. The drug, which was the crown ...

The Department of Justice (DoJ) claims that Biohaven – before being acquired by Pfizer – paid "improper remuneration" to some Nurtec ODT (rimegepant) prescribers in the form of speaker fees ...

Analyst Davide Longo from TP ICAP MIDCAP maintained a Buy rating on GPI SpA (GPI – Research Report) and keeping the price target at ...

Nurtec ODT (rimegepant) is a brand-name drug prescribed for treating and preventing migraine in adults. Nurtec ODT comes as a tablet that dissolves in your mouth. The dosage can vary depending on ...

Say hi to the newly announced global Redmi Note 14 4G. It ships with a grey case, a USB-A to USB-C cable, and a 33W charger. It comes in Black, Purple, Blue, or Lime Green colors and has no less ...

Redmi's freshly global Note 14 series features a trio of Pros - 4G, 5G (review here), and Pro+ 5G - and a pair of non-Pros - the 4G (first encounter here) and this - the Redmi Note 14 5G.

In recent trading, shares of Group 1 Automotive, Inc. (Symbol: GPI) have crossed above the average analyst 12-month target price of $457.71, changing hands for $458.81/share. When a stock reaches ...

The government asserted that Biohaven’s fraud stopped in October 2022, when Pfizer acquired the company and terminated the Nurtec speaker programmes. "We are pleased to put this legacy matter ...

Pfizer, on behalf of its subsidiary Biohaven Pharmaceutical Holding Company, agreed to pay $59,746,277 to resolve allegations that prior to Pfizer's acquisition, Biohaven paid kickbacks to physicians ...

Biohaven Pharmaceutical Holding, from March 2020 through September 2022, selected certain healthcare providers to be part of a group to promote its drug Nurtec ODT, a migraine treatment ...

World-recognized brand Pfizer has agreed to a nearly $60 million financial agreement to settle claims that a wholly-owned subsidiary, Biohaven Pharmaceutical Holding Company Ltd. (Biohaven ...

Pfizer ended the Nurtec speaker programs after paying $11.5 billion to buy Biohaven. "Patients deserve to know that their doctor is prescribing medications based on their doctor’s medical ...